|
SPCS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.88150000035981E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53539999999875E-05 |
| Normal-vs-Stage2 |
3.646100E-04 |
| Normal-vs-Stage3 |
3.185500E-04 |
| Normal-vs-Stage4 |
1.295420E-01 |
| Stage1-vs-Stage2 |
4.226600E-01 |
| Stage1-vs-Stage3 |
2.862200E-01 |
| Stage1-vs-Stage4 |
9.836200E-01 |
| Stage2-vs-Stage3 |
8.915400E-01 |
| Stage2-vs-Stage4 |
5.469200E-01 |
| Stage3-vs-Stage4 |
5.104600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.46780000007819E-07 |
| Normal-vs-AfricanAmerican |
8.429000E-04 |
| Normal-vs-Asian |
2.196800E-01 |
| Caucasian-vs-AfricanAmerican |
5.452000E-01 |
| Caucasian-vs-Asian |
9.029600E-01 |
| AfricanAmerican-vs-Asian |
7.296000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0635000042013E-08 |
| Normal-vs-Female |
6.141900E-02 |
| Male-vs-Female |
1.255320E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.335500E-03 |
| Normal-vs-Extreme_Weight |
6.57029999961978E-07 |
| Normal-vs-Obese |
3.809600E-04 |
| Normal-vs-Extreme_Obese |
4.576100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.336000E-01 |
| Normal_Weight-vs-Obese |
7.135400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.134600E-01 |
| Extreme_Weight-vs-Obese |
3.925800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.502600E-01 |
| Obese-vs-Extreme_Obese |
5.553800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.087800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.56358999999773E-05 |
| Normal-vs-Age(61-80Yrs) |
8.24929999976298E-07 |
| Normal-vs-Age(81-100Yrs) |
1.029360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.394000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.631600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.049600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.255400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.607600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.648800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.31160000005348E-06 |
| Normal-VS-Type2 PRCC |
1.51434999999811E-05 |
| Normal-VS-KIRP CIMP |
9.068400E-01 |
| Normal-VS-Unclassified PRCC |
5.420900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.403000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.879900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.694200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.370200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.951200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.978000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.45480000052412E-07 |
| Normal-vs-N1 |
5.6579000000001E-05 |
| Normal-vs-N2 |
7.434200E-01 |
| N0-vs-N1 |
7.616200E-01 |
| N0-vs-N2 |
2.073400E-01 |
| N1-vs-N2 |
2.065000E-01 |
|
|
